A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brown’s office at (650) 341-9131 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
Plans whose provider directory lists this clinician
Licence status: Delinquent · since 2000 · expires 2024-04-30 · Rush Medical College of Rush University.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$19,742
Medicare paid this office $19,742 for 51 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Largest Original Medicare bills
Long return visit (40+ min)
23
$5,904
$118
Return visit (30+ min)
14
$1,112
$79
Who their Medicare patients are
51 Original Medicare patients in 2024. Average age 75 · Women 55% · Also on Medicaid 22% · Health risk score 2.05. Above the middle of the specialty; the typical hematology-oncology clinician is at 2.04.
Conditions among them: Cancer 75% · High blood pressure 63% · COPD 37% · Chronic kidney disease 31% · Coronary heart disease 25% · Atrial fibrillation 24%.
The office billed $107,773, Medicare allowed $26,751 and paid $19,742; for 232 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
Original Medicare by year
2024
51
232
75
2.05
$107,773
$19,742
2023
73
2,388
74
1.83
$487,304
$72,730
2022
208
20,592
75
1.33
$3,394,523
$396,056
2021
285
46,319
75
1.16
$7,083,909
$981,254
2020
343
45,346
76
1.26
$7,209,372
$1,039,571
2019
475
30,921
76
1.51
$2,553,691
$783,670
2018
433
54,675
75
1.43
$3,251,392
$950,167
2017
414
48,188
76
1.57
$2,376,615
$882,384
2016
429
37,528
75
1.52
$2,078,752
$717,002
2015
448
30,870
75
1.47
$1,770,842
$713,471
2014
428
31,272
75
1.63
$1,924,247
$674,281
2013
397
27,542
75
1.52
$1,705,865
$652,766
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
Original Medicare services billed in 2023
Long return visit (40+ min)
36
$6,249
$101
New patient visit (60+ min)
27
$3,530
$131
Long return visit (40+ min)
15
$3,216
$107
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or
40
$2,179
$23
2022: 5 services
Original Medicare services billed in 2022
Injection, denosumab, 1 mg
11
$65,597
—None
Return visit (30+ min)
116
$10,959
$92
Long return visit (40+ min)
43
$10,052
$140
Injection of drug or substance under skin or into muscle
14
$1,056
$13
Infusion, normal saline solution , 1000 cc
11
$180
—None
2021: 12 services
Original Medicare services billed in 2021
Injection, denosumab, 1 mg
13
$56,695
—None
Long return visit (40+ min)
83
$32,949
$164
Return visit (30+ min)
180
$25,456
$101
Administration of chemotherapy into vein, 1 hour or less
18
$25,412
$152
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
25
$4,030
$94
Initial hospital care with moderate level of medical decision making at least 75 minutes
22
$3,996
$182
New patient visit (60+ min)
17
$3,396
$200
Telephone medical discussion with physician, 21-30 minutes
13
$1,888
$105
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
14
$1,825
$63
Injection of drug or substance under skin or into muscle
19
$1,049
$13
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or
18
$703
$31
Infusion, normal saline solution , 1000 cc
19
$358
—None
2020: 17 services
Original Medicare services billed in 2020
Injection, denosumab, 1 mg
13
$63,479
—None
Return visit (30+ min)
206
$29,423
$87
Administration of chemotherapy into vein, 1 hour or less
23
$25,591
$143
Long return visit (40+ min)
40
$7,328
$133
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
40
$5,581
$66
Administration of additional new drug or substance into vein, 1 hour or less
12
$4,970
$70
Initial hospital care with moderate level of medical decision making at least 75 minutes
23
$4,383
$183
Short return visit (20+ min)
55
$3,561
$62
Injection of additional new drug or substance into vein
18
$3,478
$16
Telephone medical discussion with physician, 21-30 minutes
30
$3,106
$97
New patient visit (60+ min)
14
$2,649
$189
Telephone medical discussion with physician, 11-20 minutes
28
$2,147
$72
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
13
$1,415
$94
Injection of drug or substance under skin or into muscle
19
$797
$14
Infusion, normal saline solution , 1000 cc
24
$373
—None
Injection, dexamethasone sodium phosphate, 1 mg
12
$87
—None
Injection, ondansetron hydrochloride, per 1 mg
12
$23
—None
2019: 22 services
Original Medicare services billed in 2019
Return visit (30+ min)
259
$39,933
$92
Administration of chemotherapy into vein, 1 hour or less
41
$22,856
$144
Initial hospital care with moderate level of medical decision making at least 75 minutes
40
$7,882
$179
Short return visit (20+ min)
96
$7,298
$60
Injection, epoetin alfa, (for non-esrd use), 1000 units
11
$6,893
—None
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
51
$6,878
$64
Long return visit (40+ min)
37
$6,249
$125
New patient visit (45+ min)
29
$4,378
$151
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
35
$4,170
$31
New patient visit (60+ min)
18
$3,398
$189
Administration of additional new drug or substance into vein, 1 hour or less
15
$3,263
$69
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
19
$2,209
$92
Advance care planning, first 30 minutes
17
$1,267
$70
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
40
$1,074
$8
Injection of drug or substance under skin or into muscle
34
$991
$16
Administration of chemotherapy into vein, each additional hour
16
$881
$30
Irrigation of implanted venous access drug delivery device
12
$730
$26
Insertion of needle into vein for collection of blood sample
40
$420
$3
Injection, ranitidine hydrochloride, 25 mg
12
$332
—None
Injection, dexamethasone sodium phosphate, 1 mg
28
$109
—None
Injection, ondansetron hydrochloride, per 1 mg
24
$60
—None
Injection, diphenhydramine hcl, up to 50 mg
14
$30
—None
2018: 21 services
Original Medicare services billed in 2018
Return visit (30+ min)
246
$37,855
$89
Administration of chemotherapy into vein, 1 hour or less
49
$32,557
$142
Injection, epoetin alfa, (for non-esrd use), 1000 units
12
$13,706
—None
Short return visit (20+ min)
113
$10,394
$61
Long return visit (40+ min)
50
$8,621
$129
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
47
$6,145
$65
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
38
$5,406
$31
Initial hospital care with moderate level of medical decision making at least 75 minutes
27
$5,221
$180
New patient visit (45+ min)
33
$4,988
$151
Administration of additional new drug or substance into vein, 1 hour or less
19
$4,738
$70
New patient visit (60+ min)
17
$3,138
$185
Injection of drug or substance under skin or into muscle
26
$2,368
$20
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
37
$1,739
$9
Administration of chemotherapy into vein, each additional hour
16
$1,180
$31
Insertion of needle into vein for collection of blood sample
38
$556
$3
Irrigation of implanted venous access drug delivery device
12
$546
$29
Injection, ranitidine hydrochloride, 25 mg
13
$535
—None
Injection, carboplatin, 50 mg
11
$248
—None
Injection, dexamethasone sodium phosphate, 1 mg
33
$125
—None
Injection, ondansetron hydrochloride, per 1 mg
28
$50
—None
Injection, diphenhydramine hcl, up to 50 mg
13
$31
—None
2017: 17 services
Original Medicare services billed in 2017
Injection, pegfilgrastim, 6 mg
13
$119,014
—None
Return visit (30+ min)
190
$33,809
$94
Administration of chemotherapy into vein, 1 hour or less
50
$31,401
$140
Short return visit (20+ min)
174
$16,007
$62
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
60
$10,051
$64
Long return visit (40+ min)
36
$5,503
$131
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
39
$5,434
$31
Initial hospital care with moderate level of medical decision making at least 75 minutes
26
$5,411
$180
Administration of additional new drug or substance into vein, 1 hour or less
17
$4,972
$67
Injection of drug or substance under skin or into muscle
34
$3,606
$25
New patient visit (45+ min)
20
$3,028
$151
New patient visit (60+ min)
14
$2,609
$186
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
37
$1,599
$10
Administration of chemotherapy into vein, each additional hour
18
$1,561
$28
Insertion of needle into vein for collection of blood sample
39
$476
$3
Injection, dexamethasone sodium phosphate, 1 mg
32
$160
—None
Injection, ondansetron hydrochloride, per 1 mg
29
$68
—None
2016: 23 services
Original Medicare services billed in 2016
Return visit (30+ min)
173
$30,065
$94
Administration of chemotherapy into vein, 1 hour or less
54
$22,358
$139
Short return visit (20+ min)
194
$17,766
$61
Injection, epoetin alfa, (for non-esrd use), 1000 units
11
$8,577
—None
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
51
$7,592
$64
Injection, docetaxel, 1 mg
11
$6,462
—None
Injection, palonosetron hcl, 25 mcg
20
$6,101
—None
Long return visit (40+ min)
34
$5,144
$135
Administration of additional new drug or substance into vein, 1 hour or less
23
$4,744
$65
Initial hospital care with moderate level of medical decision making at least 75 minutes
21
$3,968
$180
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
49
$3,879
$31
New patient visit (45+ min)
27
$3,735
$138
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
18
$3,196
$69
Injection of drug or substance under skin or into muscle
35
$3,133
$25
Administration of chemotherapy into vein, each additional hour
21
$1,263
$29
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
44
$1,194
$10
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
11
$1,180
—None
Injection, carboplatin, 50 mg
15
$637
—None
Insertion of needle into vein for collection of blood sample
47
$444
$3
Irrigation of implanted venous access drug delivery device
11
$422
$23
Injection, dexamethasone sodium phosphate, 1 mg
43
$180
—None
Injection, ondansetron hydrochloride, per 1 mg
33
$45
—None
Injection, diphenhydramine hcl, up to 50 mg
13
$16
—None
2015: 21 services
Original Medicare services billed in 2015
Injection, pegfilgrastim, 6 mg
11
$55,687
—None
Return visit (30+ min)
191
$31,740
$93
Administration of chemotherapy into vein, 1 hour or less
51
$26,413
$139
Short return visit (20+ min)
202
$17,647
$64
Long return visit (40+ min)
67
$9,424
$126
Injection, zoledronic acid, 1 mg
16
$6,819
—None
Injection, palonosetron hcl, 25 mcg
22
$6,175
—None
New patient visit (45+ min)
39
$5,912
$152
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
50
$5,630
$65
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
20
$4,134
$70
Initial hospital care with moderate level of medical decision making at least 75 minutes
18
$3,439
$181
Administration of additional new drug or substance into vein, 1 hour or less
20
$3,195
$65
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
38
$2,675
$30
Injection of drug or substance under skin or into muscle
32
$2,222
$25
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
42
$1,473
$10
Administration of chemotherapy into vein, each additional hour
22
$1,372
$29
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
11
$1,023
$93
Irrigation of implanted venous access drug delivery device
14
$950
$26
Insertion of needle into vein for collection of blood sample
45
$441
$3
Injection, dexamethasone sodium phosphate, 1 mg
38
$125
—None
Injection, ondansetron hydrochloride, per 1 mg
17
$18
—None
2014: 26 services
Original Medicare services billed in 2014
Injection, pegfilgrastim, 6 mg
18
$92,050
—None
Return visit (30+ min)
129
$27,959
$95
Administration of chemotherapy into vein, 1 hour or less
56
$26,676
$138
Short return visit (20+ min)
201
$18,585
$62
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
76
$11,173
$64
Injection, epoetin alfa, (for non-esrd use), 1000 units
14
$10,432
—None
Injection, palonosetron hcl, 25 mcg
24
$8,312
—None
Long return visit (40+ min)
45
$6,316
$132
Injection, zoledronic acid, 1 mg
12
$6,048
—None
Administration of additional new drug or substance into vein, 1 hour or less
27
$5,740
$64
New patient visit (45+ min)
37
$5,527
$149
Administration of chemotherapy into vein, each additional hour
33
$4,015
$28
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
43
$3,918
$30
Initial hospital care with moderate level of medical decision making at least 75 minutes
17
$3,061
$180
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
30
$3,053
$93
Injection of drug or substance under skin or into muscle
38
$2,715
$25
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
63
$1,893
$10
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
17
$1,776
$68
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
12
$913
—None
Injection, paclitaxel, 30 mg
12
$780
—None
Irrigation of implanted venous access drug delivery device
19
$672
$24
Insertion of needle into vein for collection of blood sample
67
$564
$3
Injection, dexamethasone sodium phosphate, 1 mg
45
$170
—None
Injection, ondansetron hydrochloride, per 1 mg
28
$36
—None
Injection, diphenhydramine hcl, up to 50 mg
13
$20
—None
Injection, heparin sodium, (heparin lock flush), per 10 units
15
$7
—None
2013: 24 services
Original Medicare services billed in 2013
Injection, pegfilgrastim, 6 mg
11
$56,455
—None
Administration of chemotherapy into vein, 1 hour or less
56
$37,466
$144
Return visit (30+ min)
140
$29,915
$93
Short return visit (20+ min)
187
$16,740
$60
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes
60
$8,751
$63
Injection, palonosetron hcl, 25 mcg
20
$5,581
—None
Long return visit (40+ min)
33
$5,480
$125
Administration of additional new drug or substance into vein, 1 hour or less
23
$5,165
$74
Administration of chemotherapy into vein, each additional hour
36
$4,626
$31
New patient visit (45+ min)
29
$4,282
$148
Injection of drug or substance under skin or into muscle
29
$2,895
$26
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
30
$2,729
$32
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
56
$1,992
$11
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes
19
$1,851
$88
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
13
$1,788
$69
Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more
12
$1,240
$62
Injection, paclitaxel, 30 mg
16
$1,140
—None
Insertion of needle into vein for collection of blood sample
59
$618
$3
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes
11
$439
$34
Irrigation of implanted venous access drug delivery device
11
$289
$24
Injection, dexamethasone sodium phosphate, 1 mg
42
$116
—None
Injection, ondansetron hydrochloride, per 1 mg
28
$97
—None
Injection, heparin sodium, (heparin lock flush), per 10 units
30
$39
—None
Injection, diphenhydramine hcl, up to 50 mg
21
$34
—None
Medicaid work
$620 in 2024
Medicaid paid $620 for 16 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
Largest Medicaid services in 2024
Long return visit (40+ min)
16
$620
Medicaid work by year
2024
16
1
13
$620
Drugs they prescribed that Part D paid
$300,622
Pharmacies billed $300,622 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
107 generic and 28 brand-name prescriptions · $300,622 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Anastrozole
20
$456
$23
Year by year
Part D prescribing by year
2024
135
44
—None
21%
$300,622
2023
203
68
—None
8%
$314,812
2022
551
171
—None
8%
$439,760
2021
948
225
1% (11)
7%
$610,152
2020
934
225
1% (12)
7%
$687,994
2019
677
188
—None
4%
$311,627
2018
790
196
—None
8%
$378,783
2017
957
199
1% (13)
9%
$495,246
2016
1,076
212
1% (12)
8%
$309,789
2015
1,180
231
2% (21)
9%
$116,857
2014
1,318
207
1% (15)
—None
$382,120
2013
1,169
182
2% (20)
12%
$167,884
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
Part D drugs prescribed in 2023
Anastrozole
32
$787
$25
Ondansetron
28
$280
$10
Prochlorperazine Maleate
30
$256
$9
Dexamethasone
14
$169
$12
2022: 7 drugs
Part D drugs prescribed in 2022
Ibrance
27
$403,802
$14,956
Exemestane
35
$14,913
$426
Anastrozole
257
$8,895
$35
Letrozole
49
$2,275
$46
Tamoxifen Citrate
44
$1,650
$38
Alendronate
38
$584
$15
Gabapentin
22
$328
$15
2021: 12 drugs
Part D drugs prescribed in 2021
Ibrance
29
$393,117
$13,556
Exemestane
51
$18,582
$364
Anastrozole
442
$16,150
$37
Xarelto
13
$6,753
$519
Eliquis
13
$6,417
$494
Tamoxifen Citrate
70
$3,965
$57
Letrozole
76
$3,776
$50
Alendronate
61
$1,086
$18
Gabapentin
36
$542
$15
Potassium Chloride
19
$312
$16
Lorazepam
28
$88
$3
Prednisone
11
$67
$6
2020: 13 drugs
Part D drugs prescribed in 2020
Ibrance
20
$251,674
$12,584
Revlimid
13
$213,517
$16,424
Exemestane
47
$21,058
$448
Anastrozole
464
$16,858
$36
Tamoxifen Citrate
53
$3,565
$67
Letrozole
84
$3,404
$41
Alendronate
68
$1,119
$16
Gabapentin
24
$226
$9
Dexamethasone
16
$217
$14
Prochlorperazine Maleate
16
$191
$12
Potassium Chloride
11
$150
$14
Venlafaxine
11
$149
$14
Lorazepam
13
$56
$4
2019: 5 drugs
Part D drugs prescribed in 2019
Exemestane
45
$19,052
$423
Anastrozole
387
$13,492
$35
Tamoxifen Citrate
54
$3,108
$58
Letrozole
65
$1,636
$25
Alendronate
33
$503
$15
2018: 9 drugs
Part D drugs prescribed in 2018
Revlimid
11
$159,801
$14,527
Exemestane
73
$33,173
$454
Anastrozole
366
$11,000
$30
Eliquis
12
$5,190
$433
Tamoxifen Citrate
70
$3,316
$47
Letrozole
67
$1,975
$29
Alendronate
56
$684
$12
Zolpidem
26
$168
$6
Venlafaxine Hcl Er
12
$165
$14
2017: 11 drugs
Part D drugs prescribed in 2017
Ibrance
16
$178,262
$11,141
Tykerb
19
$131,156
$6,903
Exemestane
99
$42,561
$430
Anastrozole
388
$10,357
$27
Tamoxifen Citrate
108
$4,980
$46
Letrozole
51
$1,495
$29
Alendronate
85
$866
$10
Dexamethasone
13
$306
$24
Zolpidem
24
$289
$12
Methotrexate
14
$212
$15
Venlafaxine Hcl Er
24
$204
$8
2016: 11 drugs
Part D drugs prescribed in 2016
Exemestane
139
$45,950
$331
Fondaparinux
14
$30,585
$2,185
Anastrozole
443
$9,830
$22
Tamoxifen Citrate
104
$3,499
$34
Enoxaparin
11
$2,500
$227
Letrozole
72
$1,357
$19
Alendronate
97
$836
$9
Zolpidem
22
$537
$24
Methotrexate
13
$197
$15
Gabapentin
27
$130
$5
Lorazepam
13
$78
$6
2015: 12 drugs
Part D drugs prescribed in 2015
Exemestane
153
$61,090
$399
Anastrozole
514
$9,684
$19
Arimidex
12
$5,791
$483
Tamoxifen Citrate
114
$4,312
$38
Enoxaparin
11
$3,619
$329
Alendronate
99
$884
$9
Letrozole
49
$756
$15
Zolpidem
25
$689
$28
Gabapentin
41
$175
$4
Dexamethasone
15
$151
$10
Lorazepam
11
$145
$13
Fluoxetine
12
$106
$9
2014: 14 drugs
Part D drugs prescribed in 2014
Afinitor
16
$145,866
$9,117
Exemestane
184
$60,247
$327
Fondaparinux
12
$36,678
$3,057
Anastrozole
545
$15,040
$28
Arimidex
12
$5,352
$446
Tamoxifen Citrate
129
$3,699
$29
Alendronate
98
$1,489
$15
Letrozole
51
$1,171
$23
Venlafaxine Hcl Er
24
$638
$27
Potassium Chloride
18
$546
$30
Zolpidem
34
$225
$7
Dexamethasone
16
$167
$10
Gabapentin
24
$102
$4
Sertraline
14
$94
$7
2013: 9 drugs
Part D drugs prescribed in 2013
Exemestane
139
$47,233
$340
Anastrozole
513
$17,975
$35
Tamoxifen Citrate
134
$2,933
$22
Lunesta
12
$2,835
$236
Alendronate
122
$2,048
$17
Letrozole
34
$867
$26
Potassium Chloride
17
$384
$23
Hydrocodone-Acetaminophen
12
$141
$12
Zolpidem
18
$103
$6
Money from drug and device companies
$31 in 2025
Industry payments by year
2025
1
1
—None
$31
2022
2
4
—None
$177
2021
5
7
—None
$325
2020
2
5
—None
$68
2019
1
3
—None
$40
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.